Filter by
Filter by
Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.
This is a retrospective analysis of 16 patients who received PBRT reRT for recurrent meningiomas. The median PBRT dose was 60 Gy(RBE) and the median follow-up...
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
This study compared PBS toxicity rates with those of passive scattering/uniform scanning (PS/US) in a prospective multicenter registry. For low-to-intermediate...
Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.
A cohort of 146 patients with low-risk prostate cancer were treated to 60 Gy (cobalt Gy equivalent) of proton therapy (20 fractions of 3.0 Gy per fraction) in 4...
Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.
This retrospective study analyzing 16 patients with locally recurrent breast cancer who underwent re-irradiation to the chest wall with PBT to the median dose...
High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer.
Perineural invasion (PNI) is an uncommon (<5%) which refers to tumor cell invasion extensive enough to cause clinically detectable deficits of the involved...